Archive · 23 Jul 2026
Novartis India Reports 16.59% Profit Increase
Novartis India, a pharmaceutical company, recently announced its financial results for the quarter ending in June 2026.
The company made a net profit of ₹32.21 crore, which is 16.59% more than the same period last year.
The company's total income was ₹112.55 crore, and its expenses were ₹69.38 crore.
Additionally, Novartis AG sold a large portion of its shares in Novartis India to other investors.
The company also mentioned that new labor laws in India increased their employee benefit expenses by ₹79 lakh.
Overall, the company's financial performance improved compared to the previous year.
Novartis India reported a 16.59% increase in net profit after tax for Q2 2026.
Revenue from operations rose to ₹103.81 crore, up from ₹87.55 crore year-on-year.
Total income for the quarter reached ₹112.55 crore, with total expenses at ₹69.38 crore.
Profit before tax increased to ₹43.17 crore, and earnings per share rose to ₹13.05.
Novartis AG sold 70.68% of its equity shares in Novartis India to new investors.
- Who
- Novartis India Limited
- What
- Reported a 16.59% increase in net profit after tax for the quarter ended 30 June 2026
- When
- Quarter ended 30 June 2026, announced on 23 July 2026
- Where
- Mumbai, India
- Why
- Due to increased revenue and operational efficiency
Investor Perspective
Regulatory Perspective
Share Acquisition
Investor Perspective
Investors benefit from the acquisition and potential stock price increase.
Regulatory Perspective
Regulators ensure compliance with labor codes and financial transparency.
- Net Profit After Tax
- ₹32.21 crore
- Revenue from Operations
- ₹103.81 crore
- Total Income
- ₹112.55 crore
- Total Expenses
- ₹69.38 crore
- Profit Before Tax
- ₹43.17 crore
- Earnings Per Share
- ₹13.05
- Shares Acquired
- 1,74,50,680
- Percentage of Equity Capital
- 70.68%
